Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

Bijal D. Shah, Ryan D. Cassaday, Jae H. Park, Roch Houot, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O'Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. WierdaDaniel J. Deangelo, Patrick J. Stiff, Deepa Jeyakumar, Daqin Mao, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Rita Damico Khalid, Armin Ghobadia

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3'. Together they form a unique fingerprint.

Medicine & Life Sciences